Vitreo-Retina Services, Aravind Eye Hospital, Thavalakuppam, Pondicherry, India.
Indian J Ophthalmol. 2022 Jan;70(1):308-309. doi: 10.4103/ijo.IJO_1757_21.
Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives all across the world, there are a few case reports on post-vaccine thrombotic events seen with the AZD1222, ChAdO × 1 vaccine. Here, we present two cases of central retinal vein occlusion presenting immediately after receiving the second dose of the Covishield vaccine. Although the causal relationship cannot be drawn, the ophthalmologist should be aware of this adverse reaction.
2019 年冠状病毒病（COVID-19）除急性呼吸窘迫综合征（ARDS）外，已知还会引起血栓栓塞事件。随着全球范围内大规模疫苗接种活动的开展，出现了少数与阿斯利康（AZD1222）和 ChAdOx1 疫苗接种相关的疫苗后血栓事件病例报告。在此，我们报告两例在接种 Covishield 疫苗第二剂后立即出现视网膜中央静脉阻塞的病例。虽然不能确定因果关系，但眼科医生应该了解这种不良反应。
